2cureX presents commercial roadmap 2021 – 2023
CEO Ole Thastrup and CBO Maarten van der Linden present 2cureX’s roadmap for commercialization of IndiTreat® at three investor meetings in November: Danish Shareholders’ Association (InvestorUgen), Copenhagen on 12. November, Life Science Day Life Science, Copenhagen on 25. November and Redeye Life Science Day, Stockholm on 26. November.
Inlägget 2cureX presents commercial roadmap 2021 – 2023 dök först upp på IPO. se.